Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma
- Jesús San-Miguel
- , Joan Bladé
- , Ofer Shpilberg
- , Sebastian Grosicki
- , Frédéric Maloisel
- , Chang Ki Min
- , Marta Polo Zarzuela
- , Tadeusz Robak
- , Sripada V.S.S. Prasad
- , Yeow Tee Goh
- , Jacob Laubach
- , Andrew Spencer
- , María Victoria Mateos
- , Antonio Palumbo
- , Tom Puchalski
- , Manjula Reddy
- , Clarissa Uhlar
- , Xiang Qin
- , Helgi Van De Velde
- , Hong Xie
Research output: Contribution to journal › Article › peer-review
132
Scopus
citations